Randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation. Ann Surg 2014; 259: 888-893.

Published: 11th June 2014

Authors: Pilch N, Taber DJ, Moussa O, Beje T, Denmark S, Meadows HB et al.

Conclusion

One year rejection rates were similarly low (10 per cent IL-2 antagonist versus 6 per cent for antithymocyte globulin). In black patients, however, antithymocyte globulin gave improved protection.

Pubmed Link

Your comments

0 Comments